Ye Y - Search Results

1

Prevalence of monoclonal gammopathy of undetermined significance in Shenzhen, China.

Xu A, Guo T, Zhang S, Luo H, Shen M, Ye Y, Ji L. Xu A, et al. Among authors: ye y. Hematology. 2024 Dec;29(1):2352686. doi: 10.1080/16078454.2024.2352686. Epub 2024 May 31. Hematology. 2024. PMID: 38819332 Free article.

2

Mutational spectrum of HBD gene in the Chinese population: Description of 36 mutations including 11 novel variants.

Xu A, Li M, Ye Y, Li L, Ma M, Wu SY, Ji L. Xu A, et al. Among authors: ye y. Int J Lab Hematol. 2023 Dec;45(6):961-968. doi: 10.1111/ijlh.14155. Epub 2023 Aug 22. Int J Lab Hematol. 2023. PMID: 37605839

3

Identification of Hb Lepore, Hb anti-Lepore, and α-globin gene triplications by long-read single-molecule real-time sequencing.

Xu A, Ye Y, Huang Y, Huang Y, Guo H, Ji L. Xu A, et al. Among authors: ye y. Am J Clin Pathol. 2024 Apr 3;161(4):411-417. doi: 10.1093/ajcp/aqad155. Am J Clin Pathol. 2024. PMID: 38037185

4

Identification of tumor heterogeneity associated with KRAS/TP53 co-mutation status in lung adenocarcinoma based on single-cell RNA sequencing.

Ye YH, Zhang YT, Luo YL, Xu AP, Ji L. Ye YH, et al. Am J Cancer Res. 2024 Feb 15;14(2):655-678. doi: 10.62347/NXAJ9418. eCollection 2024. Am J Cancer Res. 2024. PMID: 38455404 Free PMC article.

5

A New Hemoglobin Variant: Hb Tangshan [HBA1: c.239C > T, CD79(GCG > GTG)(Ala > Val)] Detected by MALDI-TOF MS.

Xu A, Ge S, Huang Y, Xie W, Ye Y, Lin C, Ji L. Xu A, et al. Among authors: ye y. Hemoglobin. 2023 Sep;47(5):202-204. doi: 10.1080/03630269.2023.2277445. Epub 2023 Dec 7. Hemoglobin. 2023. PMID: 37909121

6

Leveraging senescence-oxidative stress co-relation to predict prognosis and drug sensitivity in breast invasive carcinoma.

Ye Y, Luo Y, Guo T, Zhang C, Sun Y, Xu A, Ji L, Ou J, Wu SY. Ye Y, et al. Front Endocrinol (Lausanne). 2023 Aug 4;14:1179050. doi: 10.3389/fendo.2023.1179050. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37600707 Free PMC article.

7

Prognosis stratification of patients with breast invasive carcinoma based on cysteine metabolism-disulfidptosis affinity.

Zhang Y, Ye Y, Xu A, Luo Y, Sun Y, Zhang W, Ji L. Zhang Y, et al. Among authors: ye y. J Cancer Res Clin Oncol. 2023 Oct;149(13):11979-11994. doi: 10.1007/s00432-023-05028-y. Epub 2023 Jul 8. J Cancer Res Clin Oncol. 2023. PMID: 37422541

8

New insights into COL26A1 in thyroid carcinoma: prognostic prediction, functional characterization, immunological drug target and ceRNA network.

Luo Y, Ye Y, Zhang Y, Chen L, Qu X, Yi N, Ran J, Chen Y. Luo Y, et al. Among authors: ye y. Transl Cancer Res. 2023 Dec 31;12(12):3384-3408. doi: 10.21037/tcr-23-141. Epub 2023 Dec 27. Transl Cancer Res. 2023. PMID: 38197076 Free PMC article.

9

A degradome-based prognostic signature that correlates with immune infiltration and tumor mutation burden in breast cancer.

Luo Y, Ye Y, Chen Y, Zhang C, Sun Y, Wang C, Ou J. Luo Y, et al. Among authors: ye y. Front Immunol. 2023 Mar 13;14:1140993. doi: 10.3389/fimmu.2023.1140993. eCollection 2023. Front Immunol. 2023. PMID: 36993976 Free PMC article.

10

Inhibition of USP10 induces myeloma cell apoptosis by promoting cyclin D3 degradation.

Xu YJ, Zeng K, Ren Y, Mao CY, Ye YH, Zhu XT, Sun ZY, Cao BY, Zhang ZB, Xu GQ, Huang ZQ, Mao XL. Xu YJ, et al. Among authors: ye yh. Acta Pharmacol Sin. 2023 Sep;44(9):1920-1931. doi: 10.1038/s41401-023-01083-w. Epub 2023 Apr 13. Acta Pharmacol Sin. 2023. PMID: 37055530 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11,627 results

Search Page

Filters